Image
![A line drawing of a laptop and a cup of coffee](/sites/default/files/2020-12/hero-laptop.png)
Harm reduction strategies and tools should be accessible to everyone – regardless of location, time, and/or experience.
A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).